PGx Testing: Specialists Benefit From, and Build Upon Oncology’s Success

Oncologists are considered one of the earliest adopters of PGx – for good reason. Other specialities can look towards their successes to bring PGx into their realm of healthcare.

“Cardiologists and endocrinologists[…] might find that patients are struggling with side effects triggered by statins that are influenced by PGx – and therefore those patients quit taking their medications. PGx testing allows these specialists not only to choose the medications most likely to be well tolerated but also convince skeptical patients in advance that they are unlikely to experience side effects, thanks to close attention to their unique genetic makeup” – Carla Balch, founder of Spesana

Carla goes further in-depth into how oncology has adopted PGx and the benefits they’ve seen in: “PGx Testing: Specialists Benefit From, and Build Upon Oncology’s Success”. Read the full article in MedCity News: https://medcitynews.com/2026/02/pgx-testing-specialists-benefit-from-and-build-upon-oncologys-success/